Current role
Barbara Hibner
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Barbara Hibner
Decoy Therapeutics Inc. reported in an 8-K filed November 19, 2025 that Barbara Hibner was appointed Chief Scientific Officer. Decoy Therapeutics Inc. reported in an 8-K filed November 13, 2025 that Barbara Hibner was appointed Chief Scientific Officer, effective November 12, 2025.
“On November 18, 2025, the Company and each of Mr. Frederick E. Pierce, Dr. Barbara Hibner and Mr. Peter Marschel entered into employment agreements (the “Employment Agreements”) to serve as Chief Executive Officer, Chief Scientific Officer, and Chief Business Officer, respectively (collectively, the “Executive Officers”).”
“Also on November 12, 2025, the Company appointed Mr. Pierce as Chief Executive Officer, Dr. Barbara Hibner as Chief Scientific Officer, and Mr. Peter Marschel as Chief Business Officer.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Decoy Therapeutics Inc. (DCOY)
Proxy statement
CurrentStart not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Decoy Therapeutics Inc.
Other people whose current roles at this company are on record from its filings.
- Frederick E. Pierce CEO, Board Member
- Mark J. Rosenblum CFO
- Arnold C. Hanish Board Member
- David J. Arthur Board Member
- Jonathan Lieber Board Member
- Patricia Gauthier Board Member
- Paul Lammers Board Member
- Tess Burleson Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.